Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Nicotinamide mononucleotide
by Most Patent Filing In 1 Year in the world in 2020

The Nicotinamide mononucleotide top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 1 Year Nicotinamide mononucleotide New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
Kyoto, Japan
Patent: 3
2
SH, CN
Patent: 3
3
Osaka, Japan
Patent: 3
4
Nutrition,Health care,Arachidonic acid,
...[+2]
Patent: 2
5
Patent: 2
6
Patent: 2
7
Pennsylvania, United States
Graduate degree,Academic Training,The Internet,
...[+2]
Patent: 2
8
Patent: 2
9
Health care,Genetic engineering,Enzyme,
...[+2]
Patent: 2
10
Patent: 1
11
Patent: 1
12
Patent: 1
13
Patent: 1
14
Patent: 1
15
Patent: 1
16
Patent: 1
17
Patent: 1
18
Zhongke Health Industry Group Corp., Ltd
Patent: 1
19
Patent: 1
20
Tennessee, United States
Patent: 1
Page generation time: Dec 14 2025